Prediction of response to bacillus Calmette-Guérin treatment in non-muscle invasive bladder cancer patients through interleukin-6 and interleukin-10 ratio

This study aimed to evaluate whether the interleukin-6 (IL-6) and interleukin-10 (IL-10) ratio (IL-6/IL-10) can be used as a prognostic marker of recurrence following bacillus Calmette-Guérin (BCG) therapy in patients with high-risk non-muscle invasive bladder cancer (NMIBC). One hundred and twenty-...

Descripción completa

Detalles Bibliográficos
Autores principales: CAI, TOMMASO, NESI, GABRIELLA, MAZZOLI, SANDRA, MEACCI, FRANCESCA, TINACCI, GALLIANO, LUCIANI, LORENZO GIUSEPPE, FICARRA, VINCENZO, MALOSSINI, GIANNI, BARTOLETTI, RICCARDO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503887/
https://www.ncbi.nlm.nih.gov/pubmed/23181118
http://dx.doi.org/10.3892/etm.2012.634

Ejemplares similares

Ejemplares similares